article thumbnail

Supply chain middlemen ‘pocket half of US branded medicine spending’

pharmaphorum

The report from Berkeley Research Group (BRG) – which was funded by the pharma industry trade group PhRMA – reveals a steady decrease in the proportion received by drugmakers from around 67% in 2013 to 49.5%